Physician
Obstetrics & Gynecology
Dr. William J. Woods, MD
|
|
Give Review
Dr. William J. Woods is an expert in the field of Obstetrics & Gynecology. He went to medical school at Meharry Medical College. He has 2 awards "Chicago Magazine - Women's Health" and "Fellow (FACOG)". Dr. William J. Woods is a published doctor and has 53 publications published. The lastest was: 'Lidocaine in the horse: its pharmacological effects and their relationship to analytical findings.' He is registered with Medicare and accepts Medicare payments.
Publications
- New therapeutic approaches for equine protozoal myeloencephalitis: pharmacokinetics of diclazuril sodium salts in horses.
- Detection, quantification, metabolism, and behavioral effects of selegiline in horses.
- Detection, quantification, and pharmacokinetics of furosemide and its effects on urinary specific gravity following IV administration to horses.
- Apparent ELISA detection times for albuterol after administration with the torpex equine inhaler device.
- Genetic analysis of sensitization and tolerance to cocaine.
- Comparison of the quantification of caffeine in human plasma by gas chromatography and ELISA.
- High-sensitivity radioimmunoassay screening method for fentanyl.
- Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.
- Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems.
- Efficacy of testing for illegal medication in horses.
- Mepivacaine: its pharmacological effects and their relationship to analytical findings in the horse.
- Lidocaine in the horse: its pharmacological effects and their relationship to analytical findings.
- Direct MS-MS identification of isoxsuprine-glucuronide in post-administration equine urine.
- Remifentanil in the horse: identification and detection of its major urinary metabolite.
- Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation.
- Pyrilamine in the horse: detection and pharmacokinetics of pyrilamine and its major urinary metabolite O-desmethylpyrilamine.
- The effects of naloxone on endotoxic and hemorrhagic shock in horses.
- Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
- Pharmacokinetics and behavioral effects of methylphenidate in Thoroughbred horses.
- Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
- Phenylbutazone in the horse: a review.
- Radioimmunoassay screening for etorphine in racing horses.
- Detomidine: a preliminary analysis of its duration of action in the horse by variable interval responding.
- Development of a method for the detection and confirmation of the alpha-2 agonist amitraz and its major metabolite in horse urine.
- A GC-MS method for the determination of isoxsuprine in biological fluids of the horse utilizing electron impact ionization.
- Diclazuril in the horse: its identification and detection and preliminary pharmacokinetics.
- Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration.
- Radioimmunoassay for etorphine in horses with a 125I analog of etorphine.
- Evaluation of threshold doses of drug action in the horse using hematocrit values as an indicator.
- Absence of detectable pharmacological effects after oral administration of isoxsuprine.
- Character and duration of pharmacological effects of intravenous isoxsuprine.
- A review of the pharmacology, pharmacokinetics, and regulatory control in the US of local anaesthetics in the horse.
- Regulatory significance of procaine residues in plasma and urine samples: preliminary communication.
- Determination of highest no effect dose (HNED) for local anaesthetic responses to procaine, cocaine, bupivacaine and benzocaine.
- Frequency distribution of post race urine pH from standardbreds compared with thoroughbreds: research and regulatory significance.
- Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean administration.
- The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.
- Pharmacologic effects and detection methods of methylated analogs of fentanyl in horses.
- Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horses.
- Hordenine: pharmacology, pharmacokinetics and behavioural effects in the horse.
- Immunoassay detection of drugs in racing horses. IX. Detection of detomidine in equine blood and urine by radioimmunoassay.
- Morphine and etorphine: XIV. Detection by ELISA in equine urine.
- Identification of lidocaine and its metabolites in post-administration equine urine by ELISA and MS/MS.
- Immunoassay detection of drugs in racing horses: detection of ethacrynic acid and bumetanide in equine urine by ELISA.
- Immunoassay detection of drugs in racing horses. VII. Detection of acepromazine in equine urine and blood by ELISA and PCFIA.
- Intratracheal clenbuterol in the horse: its pharmacological efficacy and analytical detection.
- The detection, pharmacokinetics and behavioral effects of diisopropylamine dichloroacetate (DADA) in the horse: a preliminary report.
- Immunoassay detection of drugs in racing horses. XI. ELISA and RIA detection of fentanyl, alfentanil, sufentanil and carfentanil in equine blood and urine.
- Immunoassay detection of drugs in racing horses. VI. Detection of furosemide (Lasix) in equine blood by a one step ELISA and PCFIA.
- Immunoassay detection of drugs in racing horses. IV. Detection of fentanyl and its congeners in equine blood and urine by a one step ELISA assay.
- Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse.
- Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses.
Schools
Medical College Of GeorgiaAugusta Ga
Memorial Health UniversitySavannah Ga
Mem Health
Procedures Preformed
- EKG (Electrocardiogram, ECG)
- Physical Examination
Doctors Specialties
- Internal Medicine
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Chicago Magazine - Women's Health
- Fellow (FACOG)
Education
-
Madigan Healthcare System -
Meharry Medical College
Hospital
-
Northwestern Memorial Hospital
Drug Facts
| NPI NUMBER | 1730117193 | |
| NPPES Provider LastName | WOODS | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 312106558 | |
| NPPES Provider State | GA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 15081.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 503.0 | |
| Percent Opioid Claims | 3.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730117193 |
| Last Name Of The Provider | WOODS |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
Dr. Julian C. Hutchins Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Germame H. Ajebo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth R. Williams Jr., MD |
|
|
Dr. Sheree E. Walker, MD |
|
|
Dr. Kerry D. Holliman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Beverly B. Sanders III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernest H. Carlton, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen M. Durkee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher A. Hendry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nnaemeka M. Umerah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Potacia W. Francis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tiffany D. Woods, MD |
|
|
Dr. Misti B. Patel, MD
This Doctor is OpenDoctor Recommended.
|